Congratulations! Metabolism and Target Organ Damage Achieves a First CiteScore of 3.0

On June 5, 2024, Elsevier officially released the 2023 CiteScore™ metrics, and we are thrilled to share that Metabolism and Target Organ Damage achieved an impressive CiteScore of 3.0 for 2023. This noteworthy accomplishment highlights the journal’s increasing influence and the high quality of research it presents in the field of metabolism. CiteScore, a metric provided by Elsevier, gauges the average number of citations garnered per document published in a journal over a four-year span. Researchers, librarians, and academic institutions use CiteScore to assess and compare the quality and impact of journals.

Highly Cited Articles for Recommendation (2022-2023):

1. Effect of cofactors on NAFLD/NASH and MAFLD. A paradigm illustrating the pathomechanics of organ dysfunction

Full text: https://www.oaepublish.com/articles/mtod.2022.14

Authors: Amedeo Lonardo, Ashwani K. Singal, Natalia Osna, Kusum K. Kharbanda

2. Liver fibrosis in nonalcoholic fatty liver disease patients: Noninvasive evaluation and correlation with cardiovascular disease and mortality

Full text: https://www.oaepublish.com/articles/mtod.2022.23

Authors: Stefano Ballestri,Alessandro Mantovani, Maria Di Girolamo, Enrica Baldelli, Mariano Capitelli, Amedeo Lonardo

3. Concise review: gamma-glutamyl transferase - evolution from an indiscriminate liver test to a biomarker of cardiometabolic risk

Full text: https://www.oaepublish.com/articles/mtod.2022.20

Authors: Amedeo Lonardo, Gjin Ndrepepa

4. Metabolic primary liver cancer in adults: risk factors and pathogenic mechanisms

Full text: https://www.oaepublish.com/articles/mtod.2022.38

Authors: Simonetta Lugari, Enrica Baldelli, Amedeo Lonardo

5. Metabolism and cancer-select topics

Full text: https://www.oaepublish.com/articles/mtod.2022.05

Authors: Fulvio Lonardo, Casem Ballouk

6. Sarcopenia in the setting of nonalcoholic fatty liver

Full text: https://www.oaepublish.com/articles/mtod.2021.16

Authors: Marco Arrese, Claudio Cabello-Verrugio, Juan Pablo Arab, Francisco Barrera, Rene Baudrand, Francisco J. Guarda, Iram Gul, Daniel Cabrera

7. Assessing strategies to target screening for advanced liver fibrosis among overweight and obese patients

Full text: https://www.oaepublish.com/articles/mtod.2022.08

Authors: Fernando Bril, Eddison Godinez Leiva, Romina Lomonaco, Sulav Shrestha, Srilaxmi Kalavalapalli, Meagan Gray, Kenneth Cusi

8. The growing prevalence of nonalcoholic fatty liver disease (NAFLD), determined by fatty liver index, amongst young adults in the United States. A 20-year experience

Full text: https://www.oaepublish.com/articles/mtod.2022.24

Authors: Wenhao Li, Cheng Han Ng, Jingxuan Quek, Kai En Chan, Caitlyn Tan, Rebecca Wenling Zeng, Jie Ning Yong, Hannah Tay, Darren Jun Hao Tan, Wen Hui Lim, Douglas Chee, Jinyang Ho, Nicholas W.S. Chew, Lung Yi Mak, Mohammad Shadab Siddiqui, Arun Sanyal, William Alazawi, Naim Alkouri, Mark Muthiah, Mazen Noureddin

9. Chronic obstructive pulmonary disease (COPD) and metabolic fatty liver syndromes: a dangerous but neglected liaison

Full text: https://www.oaepublish.com/articles/mtod.2022.06

Authors: Amedeo Lonardo, Bianca Beghe, Leonardo Michele Fabbri

10. Mechanobiology in the development and progression of nonalcoholic fatty liver disease: an updated review

Full text: https://www.oaepublish.com/articles/mtod.2022.37

Authors: Emilie K. Mitten, György Baffy

Our journal remains steadfast in its commitment to nurturing innovation and excellence in the field of metabolism. The editorial team eagerly anticipates ongoing collaboration with leading experts to further amplify the journal’s impact and contribute to the global scientific community.

Editor: Jennifer Lee
Language Editor: Catherine Yang
Production Editor: Yan Zhang
Respectfully Submitted by the Editorial Office of Metabolism and Target Organ Damage